🇺🇸 StellaLife in United States
5 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 5
Most-reported reactions
- Diarrhoea — 1 report (20%)
- Drug Hypersensitivity — 1 report (20%)
- Pharyngeal Swelling — 1 report (20%)
- Swelling Face — 1 report (20%)
- Swollen Tongue — 1 report (20%)
Other Oncology (supportive care) approved in United States
Frequently asked questions
Is StellaLife approved in United States?
StellaLife does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for StellaLife in United States?
Stony Brook University is the originator. The local marketing authorisation holder may differ — check the official source linked above.